Production and characterization of functional recombinant hybrid heteropolymers of camel hepcidin and human ferritin H and L chains
Metadatos
Mostrar el registro completo del ítemAutor
Boumaiza, Mohamed; Carmona Rodríguez-Acosta, Fernando; Poli, Maura; Asperti, Michela; Gianoncelli, Alessandra; Bertuzzi, Michela; Ruzzenenti, Paola; Arosio, Paolo; Marzouki, MohamedEditorial
Oxford University Press
Materia
Hepcidin Ferritin Heteropolymers Camel hepcidin Human ferritin H and L chains J774 cells
Fecha
2017-01Referencia bibliográfica
Boumaiza, M.; et al. Production and characterization of functional recombinant hybrid heteropolymers of camel hepcidin and human ferritin H and L chains. Protein Engineering, Design and Selection 30(2): 77-84 (2017). [http://hdl.handle.net/10481/47248]
Patrocinador
This work is partially financed by the Laboratory of Protein Engineering and Bioactive Molecules (LIP-MB) and the Doctoral School of the National Institute of Applied Sciences and Technology (INSAT-Tunis) – University of Carthage.Resumen
Hepcidin is a liver-synthesized hormone that plays a central role in the regulation of systemic iron homeostasis. To produce a new tool for its functional properties the cDNA coding for camel hepcidin-25 was cloned at the 5’end of human FTH sequence into the pASK-IBA43plus vector for expression in Escherichia coli. The recombinant fusion hepcidin–ferritin-H subunit was isolated as an insoluble iron-containing protein. When alone it did not refold in a 24-mer ferritin molecule, but it did when renatured together with H- or L-ferritin chains. We obtained stable ferritin shells exposing about 4 hepcidin peptides per 24-mer shell. The molecules were then reduced and re-oxidized in a controlled manner to allow the formation of the proper hepcidin disulfide bridges. The functionality of the exposed hepcidin was confirmed by its ability to specifically bind the mouse macrophage cell line J774 that express ferroportin and to promote ferroportin degradation. This chimeric protein may be useful for studying the hepcidin–ferroportin interaction in cells and also as drug-delivery agent.